el-Sadr, W M <br/><br/>
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG).  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  May 1998 
 - 1148-58 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1058-4838 
<br/><br/><label>Standard No.: </label>10.1086/520275  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS-Related Opportunistic Infections--drug therapy<br/>Adult<br/>Antitubercular Agents--administration & dosage<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Ethambutol--administration & dosage<br/>Female<br/>Humans<br/>Isoniazid--administration & dosage<br/>Levofloxacin<br/>Male<br/>Microbial Sensitivity Tests<br/>Mycobacterium tuberculosis--drug effects<br/>Ofloxacin--administration & dosage<br/>Pyrazinamide--administration & dosage<br/>Recurrence<br/>Rifampin--administration & dosage<br/>Sputum--microbiology<br/>Treatment Outcome<br/>Tuberculosis, Pulmonary--drug therapy